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Summary 
The murine interleukin 5 receptor (mlL-5K) is composed of two distinct subunits, ot and/~. 
The ot subunit (mlL-SKo  0 specifically binds IL-5 with low affinity. The ~ subunit (mlL-SR,8) 
does not bind IL-5 by itself, but forms the high-affinity receptor with mlL-SKot, mlL-5R/~ 
has been revealed to be the mlL-3K-like protein, AIC2B which is shared with receptors for IL-3 
and granulocyte/macrophage  colony-stimulating  factor. We demonstrated here the reconstitution 
of the functional receptors for murine and human IL-5 on the mouse IL-2-dependent cell line, 
CTLL-2. CTLL-2 was transfected with the cDNAs for mlL-SKa and/or AIC2B. Only CTLL-2 
transfectant expressing both mlL-5Ko~  and AIC2B expressed  the high-affinity receptor and 
proliferated in response to murine IL-5.  Then CTLL-2 was transfected  with the cDNAs for 
hlL-SKot and/or KH97 (tic), the human homologue of AIC2B. Though tic did not contribute 
much to binding affinity of hlL-5K, only CTLL-2 transfectant expressing both hlL-5Kot and 
tic proliferated in response to human IL-5.  These results showed that the/$ subunit is indis- 
pensable in IL-5 signal transduction. We further investigated the function of IL-5-speciiic ot subunit 
in transmitting IL-5 signals. Mutant mlL-5Ra, which lacks its whole cytoplasmic domain, was 
transfected into mouse IL-3-dependent cell line, FDC-P1 expressing AIC2B intrinsically.  The 
resulting transfectant did not respond to IL-5, though the transfectant expressed the high-affinity 
IL-5K, indicating that the cytoplasmic portion of the ot subunit also has some important role 
in IL-5-mediated signal transduction. 
I 
L-5 is a glycoprotein produced by activated T cells and mast 
. cells. IL-5 was originally identified as a cytokine that stimu- 
lates proliferation and differentiation of murine (m)  I acti- 
vated B cells, and proved to regulate the production and func- 
tion of some other hematopoietic cells, such as CD5 + B 
cells, eosinophils, and basophils (1). In humans, IL-5  acts 
mainly on eosinophils. IL-5 induces the production ~f eo- 
sinophils from bone marrow progenitors and works for sur- 
vival and priming of eosinophils in vitro. IL-5 expression was 
observed in many diseases with eosinophilia, suggesting that 
IL-5 plays important roles in promoting production and func- 
tion of eosinophils in vivo (2). 
From the series of binding and crosslinking studies,  we 
have shown that mIL-5 binds to a specific cell surface receptor 
(mIL-5K)  with both  high (Ka  =  10-150  pM)  and low 
affinity (Ka  =  2-10 nM) and that two distinct membrane 
1 Abbreviations used in this paper: h, human; m, murine; R, receptor. 
proteins, a  and 3, comprise the functional mlL-5K (3). The 
cloning of mlL-5Rot cDNA discloses molecular constitutions 
of mlL-SR (4). The mlL-5Ko~ alone binds IL-5 with low 
affinity. The mlL-5RB does not bind IL-5 by itself,  how- 
ever, it forms the high-affinity IL-5R in combination with 
the mlL-5Kot (4, 5). The mlL-SP,,8 was then identified as 
AIC2B (6), the homologous protein of the low-affinity mlL- 
3K (AIC2A[7])(8, 9). The high-affinity mlL-5K is recon- 
stituted on L cell transfectant coexpressing mlL-5Kot and 
AIC2B. Because the L cell transfectant does not respond to 
mlL-5 in DNA synthesis, it remains, however, unclear whether 
the reconstituted high-affinity mlL-5R transduces the IL- 
5-mediated signal into cell interior. 
In contrast to mlL-5K, there are controversial reports about 
human (h)IL-5R. In many cases, only a single class of hlL- 
5R with high affinity is detected on hlL-5-responsive cells, 
but its binding affinity to hlL-5 has been reported as various 
values (10-13).  There is one report describing two kinds of 
hlL-5Rs on human erythroleukemic  cell line, TF-1 (14). Some 
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ever, others show that binding of hlL-5 is competed by hlL-3 
or hGM-CSF at 4~  (cross-competition) (15). We isolated 
hlL-SRo~ by cross-species hybridization (16). The hlL-SRa 
resembles mlL-5Ra in its primary structure. It is, therefore, 
very likely that functional hlL-5R requires  the B subunits, 
and that is the human homologue of AIC2 proteins, KH97, 
the common B subunit (/3c) of hGM-CSF (receptor)  R  and 
hlL-3R (17, 18). Recent cloning of cDNAs for mlL-3Ra 
and mGM-CSFRa show that AIC2B is the common/3 sub- 
unit of the receptors  for raiL-3 and mGM-CSF (and that 
AIC2A is mlL-3R~) (19, 20).  However, COS7 cells trans- 
fected with hlL-5Ro~ cDNA binds hlL-5 with almost the 
same affinity  compared to normal eosinophils (16). It remains 
an unsolved issue how putative hlL-5R~3 contributes to the 
binding of hlL-5 and transmitting signals. 
In this report, we demonstrate the reconstitution of the 
functional receptors for m and hlL-5 on a mouse IL-2-depen- 
dent cell line, CTLL-2. In both mouse and humans, the func- 
tional IL-5R complex contains two different membrane pro- 
teins,  ol  and/3,  hlL-SR/3 is  revealed  to  be  the  common 
molecule that is shared with hlL-3R and hGM-CSFR, and 
does not contribute much to increasing the binding affinity 
of hlL-5 in contrast to the mlL-5R system. In addition, using 
mutant mlL-Sa which lacks the whole cytoplasmic domain, 
we showed that the o~ subunit has an important role not only 
in determining the binding specificity, but also in transmit- 
ting the growth signal of IL-5. 
Materials  and Methods 
Cells and Reagents.  A mouse IL-2-dependent CTLb2 cell line 
was maintained in RPMI 1640 medium supplemented with 10% 
FCS and 50/zM 2-ME and 5% conditioned medium from Con 
A-stimulated rat spleen cells. A mouse ID3-dependent FDC-P1 
cell line was maintained  in RPMI 1640 medium supplemented  with 
5% FCS, 50 #M 2-ME, and 5 U/ml of mlL-3, mlb5 was prepared 
and purified  using anti-mlb5 mAb-coupled  beads (3). Purified  hlb5 
was obtained from DNAX Research Institute. 
Plasmid Construction.  The cDNA fragments  were inserted  down- 
stream of the SRa promoter in the expression vector, pME18, the 
derivative of pCEV4 (7) (Maruyama, K., and A. Miyajima, un- 
published results). Either neomycin or hygromycin-resistant  selec- 
tion maker was added to the vectors. To construct the plasmid that 
expresses the truncated mutant mlb5R.c~, an XhoI-PstI fragment 
of mllc5Ra cDNA corresponding mostly to the extracellular  and 
transmembrane portion was excised, and then ligated into the XhoI 
and NotI armed pME18 vector, to which the bygromycin-resistant 
gene had been added, by the use of asymmetric adopters (5'GAG- 
TGTGTTAGC  and  5'GGCCGCTAACACACTCTGCA)  that 
generate a new stop codon. Resulting phsmid-encoded  mutant mlL- 
51~c~ terminated to the end of transmembrane domain (Cys, posi- 
tion 361 in mlL-SRot [4]). 
~ansfection.  Cells  were washed twice and resuspended  in Hepes 
buffered saline (pH 7.2). 107 cells per 800 #1 were then transfected 
with 50/~g of  linearized  plasmid  DNA by electroporation  by 350 V 
and 960/~F in a 0.4-cm gap cuvette using Gene Pulser (Bio-Rad 
Laboratories, Richmond, CA). Transfectants  were selected in the 
medium containing either 400/zg/ml of G418 (geneticin; Sigma 
Chemical Co., St. Louis, MO) or 200-400/~g/ml of hygromycin 
(Wako Pure Chemical Industries, Osaka, Japan), depending on the 
selection marker on the plasmid  DNA. The expression of the cDNA 
products was examined by flow cytometry analysis using mAbs 
against mlb5Rcx (H7) (21), AIC2A or AIC2B (anti-Aic-2) (22), 
and KH97 (CRS-1) (23), except for the hlL-SR~ transfectants. 
The expression of hlb5Rc~ was verified by binding assay using 
125I-hlb5. 
11_,5 Binding Assay.  Purified  hIL-5  was iodo labeled  using IODO- 
GEN  |  (Pierce Chemical Co., Rockford, IL). mII~5 were biosyn- 
thetically 3SS-methionine labeled, as  previously described (3). 
Specific activities of nSI-labeled hIL-5 and 3SS-labeled mIL-5 were 
5.5  x  106 cpm/pmol and 4.7  ￿  106 cpm/pmol, respectively. For 
binding  assay, 5-10  x  10  s cells were incubated in the binding 
medium (RPMI 1640 medium containing 25 mM Hepes, pH 7.2 
and 0.1% BSA) with increased  concentrations of radiolabeled IL-5 
at 4~  for 2 h. Cell-associated  radioactivity was separated from 
flee ligand by centrifugation through 3:2 dibutyl/dioctyl phtha- 
lates and counted. Specific binding was defined as the difference 
between total and nonspecific  binding obtained in the presence of 
100-fold molar excess of unlabeled IL-5. Binding data were ana- 
lyzed by Scatchard analysis  using the EBDA and LIGAND com- 
puter programs (Elsevier-BIOSOFT, Cambridge, UK). 
Chemical Crosslinking.  Crosslinking experiments using mIL- 
5R transfectants  were performed according to the method described 
previously (3). In brief, 5  x  104 cells were incubated with radio- 
labeled IL-5, collected, and resuspended in 500 #1 of HBSS con- 
taining 1 mM disuccinimidyl  tartarate (DST; Pierce Chemical Co.). 
After incubation at 4~  for 30 rain, cells were solubilized with 
lysis buffer (PBS containing 1% Triton X-100 and protease inhibi- 
tors). After removing insoluble fraction by centrifugation, cell ly- 
sates were subjected to SDS-PAGE (7.5% polyacrylamide)  under 
reducing condition. Gel was fixed  and dried, then analyzed  by Fijix 
BAS2000 Bioimaging Analyzer (Fuji Photo Film, Tokyo,  Japan). 
For hlL-5R transfectants, crosslinking was performed in PBS con- 
taining 200/~M disuccinimidyl  suberate (DSS; Pierce Chemical  Co.), 
instead of 1 mM DST (14). 
Proliferation Assay.  Transfectants were harvested and washed 
with HBSS, then inoculated into a 96-well microtiter plate at a 
concentration of 104/200/~1 per well with various concentrations 
of m or hlL-5. The cells were pulse labeled with [3H]thymidine 
(0.2 #Ci/weU) during the last 6 h of a 48-h culture period, and 
incorporated [3H]thymidine  was measured by a liquid scintillation 
counter. 
Results 
Reconstitution  of the Functional  mIL-SR  in lL-2-dependent 
CTLL-2  Cells.  In a previous report, we reconstituted the 
high-affinity  mlL-5R on fibroblastic L cells by coexpressing 
mlL-5Rol and AIC2B, however,  the transfectant does not 
respond to raiL-5 in DNA synthesis (8). To test the signal- 
transducing ability of recombinant mlL-SRs, we introduced 
cDNAs of the mlL-5Ra and/or AIC2B into mlL-2-depen- 
dent CTLL-2 cell line. The stable CTLL-2 transfectants ex- 
pressing mlL-SRc~ alone (CTLL-m5R~) or coexpressing mlL- 
5Rc~ and AIC2A (CTLL-mSR~x-2A) bound mlL-5 with low 
affinity (Ka  =  2-5 nM). Only the transfectant coexpressing 
mlL-5Rol and AIC2B  (CTLL-m5Ro~-2B) bound raiL-5 
not only with low but also with high affinity (Ka  =  10-60 
pM) (data not shown). These results were consistent with 
our previous observation obtained using L cell transfectants 
(8). Responsiveness  of these CTLL-2 transfectants to mlL-5 
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Figure  1.  lb5-responsiveness  of the CTLL-2 transfectants expressing 
mlbSRc~, AIC2B, and AIC2A. Cells  were  incubated  for 48 h in the pres- 
ence of various concentrations  of mIL-5 and incorporated  [3H]thymidine 
was measured. The results are expressed as the percentage  of incorpora- 
tion of [3H]thymidine  in the same  cells incubated  with 100 U/ml of hlb2. 
Data are shown in mean _+ SD of three independent  transfectant  clones. 
(0)  CTLL-m5Rc~  (expressing mlb5tk~),  (~)  CTLL-2B (expressing 
AIC2B), (ll) CTLbmSlkot-2A  (expressing  mlbSRc~  and AIC2A), and 
(O) CTLL-mSRc~-2B  (expressing mlbSIkcx and AIC2B). 
was then examined. As shown in Fig. 1, only CTLL-m5Rc~- 
2B which expressed the high-affinity mlL-51k responded to 
mlL-5 in DNA synthesis, mlL-5 induced a similar magni- 
tude of proliferative response to that induced by IL-2. CTLL- 
m5Ro~-2B could be maintained by mlL-5 in the absence of 
IL-2 for long periods of time (data not shown). 
Binding Characteristics of the hlL-5R  Transfectants.  Next, 
we established the stable CTLL-2 transfectants expressing ei- 
ther hlL-5Rc~ and/or KH97 03c). First, the hIL-5 binding 
characteristics  of  resulting  transfectants  were  examined. 
CTLL-2 expressing hlL-5Rot alone (CTLL-h5Rc~) bound 
hlL-5 with almost similar affinity (Kd  --  650-720 pM) to 
that  of normal  eosinophils  (Fig.  2,  O)  as  we  previously 
showed using COS7 cells (16). Transfectants  expressing B~ 
(CTLL-3r  did not bind hlL-5 (see Fig.  3, lanes 3  and 4). 
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Figure 2.  Scatchard  plot analysis  of t2SI-hlI:5  binding  to CTLL-2  trans- 
fectants. (O) CTLL-h51Lcx  (expressing hlL-SRo  0 and (0) CTLbhSRot- 
Be (expressing hlL-SRot  and 3r  Two independent  clones of CTLL-h5R~x 
and three clones of CTLbh5Ro~Bc  were analyzed.  The Kd values are 650 
and 720 pM for CTLbh5Rot, and 310-450 pM for CTLL-h5R~Br trans- 
fectants. The representative results were presented. 
Figure  3.  Chemical  crosslinking  of tzSI-hlL-5  to CTLb2 transfectants. 
(Lanes I and 2) CTLDh5R~x  (expressing  hII.-SR.a);  (lanes  3 and 4) CTLL- 
Be (expressing Be); and (lanes 5 and 6) CTLIchSR~-Bc  (expressing hid 
5Rot and 30- Cells were incubated  with 4 nM t2SI-hlL-5  at 4~  for 2 h 
in the presence (lanes I, 3, and 5) or absence of (lanes 2, 4, and 6) large 
molar excess of unlabeled  IbS, and were crosslinked  with DSS. The cell 
tysates  were  subjected  to SDS-PAGE  under  reducing  conditions,  and were 
analyzed by a BAS2000 Bioimaging  Analyzer (Fuji Photo Film). 
The value of binding affinity of a transfectant coexpressing 
hlL-5Rc~ and tic (CTLL-h5Ra-fl0 did not differ so much, 
but  was  slightly higher (Kd  =  310-450  pM)  (Fig.  2,  e) 
than that of CTLL-h5Ra. However, the interaction of tic 
with hlL-5Rot was confirmed by chemical crosslinking ex- 
periments. When CTLL-hSRot was incubated with 12sI-IL- 
5 and crosslinked with DSS, an ,~80-kD band corresponding 
to the complex of hlL-5tkc~  and hlL-5 was detected (Fig. 
3,  lane 2).  In contrast, when CTLL-h5Rc~-flc  was cross- 
linked with 12sI-IL-5, a •140-kD  band corresponding to the 
complex of fie and hlL-5 was detected in addition to 80-kD 
band (Fig. 3, lane 6). Though fl~ did not greatly change the 
binding affinity of hlL-5Rc~ and hlL-5, it indeed existed in 
close proximity to hlL-5 when hlL-SRo~ was expressed.  It 
is  highly  suggestive  that  fie  interacts  with  hlL-SRot  in 
binding to hlL-5. 
Reconstitution of the Functional hlL-5R.  To clarify whether 
tic is necessary for the signal transduction through IL-5R, 
the responsiveness of the transfectants was examined. As shown 
in Fig.  4,  neither CTLL-hSRc~ nor CTLL-flr  respond to 
hlL-5. Only CTLL-hSRa-fl~ responded to hlL-5 in DNA 
synthesis. Moreover,  CTLL-h5Rot-flc acquired the ability to 
proliferate in response to hlL-5 without IL-2 for more than 
2 mo (data not shown). From these results, it was confirmed 
that tic is indispensable for the functional hlL-5R. In mu- 
rine IL-2-dependent cells, reconstituted hlL-SR could associate 
to murine cytoplasmic proteins that transduce growth signals. 
Consequences  of the Deletion of the Cytoplasmic Domain of 
at Subunit.  From these transfection experiments, it was con- 
firmed that the common/3 subunit shared among receptors 
for IL-5, IL-3, and GM-CSF, AIC2B in mice and 3c (KH97) 
in humans, is indispensable to construct functional IL-SRs. 
1525  Takaki  et al. lOO 
8o 
15  6o 
[  , 
~  20- 
O~ 
o.1  1  1o  1oo  1ooo 
hlL-5 (pM) 
Figure 4.  IL-5-dependent  proliferation  of CTLb2  transfectants  ex- 
pressing hlb5Rs. Cells were incubated for 48 h in the presence  of increasing 
concentrations of hlI.-5, and incorporated 13H]thymidine was measured. 
The results are expressed as the percentage of incorporation of [3H]thymi- 
dine in the same cells incubated with 100 Units/ml of hlb2. Data are 
shown as mean _+ SD of three independent transfectant clones. (0) CTLL- 
h5Ro~ (expressing hlb5Rot),  ([2]) CTLbBc (expressing Be), and (O) 
CTLDh5Rc~-3c (expressing hlL-5R~ and ~c). 
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Figure 6.  IL-5-induced  proliferation of FDC-P1 transfectants expressing 
wild-type (ll) or mutant mIL-SRc~  ([]), and CTLb2 transfectants coex- 
pressing mutant mlb5Rc~ and AIC2B (O). Cells were incubated for 48 h 
in the  presence of various  concentrations  of mIb5  and incorporated 
[3H]thymidine was measured. The results are expressed as the percentage 
of incorporation of [3H]thymidine in the same cells incubated with 100 
U/ml of mlb3 for FDC-Pl transfectants or 100 U/ml of hIb2 for CTLIr 
transfectant. Data are shown as mean _+  SD of three independent trans- 
fectant clones. 
Sharing of the signal-transducing  molecule explains many over- 
lapping biological activities of these cytokines, particularly 
on eosinophils. However, IL-5,  IL-3, and GM-CSF induce 
different responses depending on cell types. We hypothesized 
that the signals specific for respective cytokines may exist and 
be mediated by the relevant ol subunit, specific components 
to respective receptors. To examine the mlL-SRc~ function, 
we constructed the mutant cDNA which lacks the whole cyto- 
plasmic domain (Fig. 5 A), and transfected into mouse IL-3- 
dependent FDC-P1  cells endogenously expressing AIC2B. 
First,  we examined interaction  of mutant  ol  subunit  and 
AIC2B. As shown in Fig. 5 B, the high (Kd  =  10 pM) and 
low-affnity (Kd  =  2 nM) mlL-5Rs were reconstituted on 
FDC-P1 transfectants.  The high-affnity receptor was detected 
on FDC-P1 transfectants not only at 4~  but also at 37~ 
(data not shown), indicating that mutant mlL-5Ro~ mole- 
cules were retained on ceU surface and interacted with AIC2B. 
Though  the number of high-affnity mIL-5R  on mutant 
mIL-5Rc~  transfectants  was  smaller  than  that  on  intact 
mIL-5Ro~ transfectants, it was indicated that the cytoplasmic 
portion of mIL-SRol is not indispensable to interact with 
AIC2B. This interaction was also confirmed by crosslinking 
experiment (Fig. 5 C). The ~75-kD complex of mutant mlL- 
5RoL and radio-labeled IL-5 and the '~150-kD  complex of 
AIC2B and IL-5 were detected on the FDC-P1 transfectants 
expressing the mutant c~ subunit. We next investigated the 
IL-5 responsiveness of mutant mIL-5Rol transfectants (Fig. 
6, D). FDC-P1 transfected with wild-type mIL-5Rc~ prolifer- 
Figure  5.  (A) Schematic representation of wild-type (left)  and mutant mlb5Rcr  (right).  The extracellular portion of the mlL-SRc~  is divided into 
three fibronectin-like domains (16). (Hatched box, cytoplasmic domain) Region (RLFPpl/vPxxxg/Rxxg/ixD) conserved among each ~ subunit of IL-SR, 
Ib3R, and GM-CSFR. Stop codon was generated just below the transmembrane domain, and the resulting mutant mlL-5R~ lacks the whole cyto- 
plasmic domain. (B) Scatchard plot analysis of binding of 3sS-mlL-5  to FDC-P1 transfectants. (O) FDC-P1 transfectant expressing mutant mIbSR~; 
and (O) FDC-PI transfectant expressing wild-type mlb5Rot. (C~ Crosslinking of radiolabeled mi1r  to the transfectant expressing mutant mlb5R~. 
Chemical crosslinking was performed in the presence (lane I) or absence (lane 2) of 100-fold molar excess of unlabeled Ib5. The cell lysates were 
subjected to SDS-PAGE under reducing conditions,  and were analyzed by BAS2000 Bioimaging Analyzer (Fuji Photo Film). 
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trast, FDC-P1 transfectants expressing mutant mlL-SRc~ did 
not respond to mlL-5. We obtained essentially the same re- 
sult with CTLL-2 transfectants. CTLL-2 transfectants coex- 
pressing mutant mlL-SRoL and AIC2B did not respond to 
raiL-5 (Fig. 6, O). The IL-5-mediated growth signal was 
never transmitted through the high-affinity IL-SR that con- 
sisted of mutant c~ and wild-type/3 subunit, indicating that 
the cytoplasmic domain of IL-5Rcr has some important roles 
in transmitting IL-5 signals. 
Discussion 
We showed that both the ot and/3 subunits are indispens- 
able to form the functional IL-5K.  hlL-SRB was revealed 
to be the same molecule to the common B subunit (jSc) of 
receptors for hGM-CSF and hlL-3.  In contrast to mlL-SR, 
or to receptors for hlL-3 and hGM-CSF,  Bc did not con- 
tribute much to hlL-5 binding affinity. We observed the same 
result using L cell or COS7 cell transfectants (data not shown), 
indicating that the same affinity of the reconstituted hlL-5R 
is independent of the nature of the parental cell line used for 
transfection. In other words, the hlL-5 binding is fully recon- 
stituted by coexpressing  hlL-SRot  and ~c. Tavenier et al. 
(24) have also reported that/3c is hlL-5RB.  They isolated 
cDNAs encoding the soluble form of hlL-5Rol, and reported 
that COS cells expressing chimeric human-mouse IL-5Rot 
bind hlL-5 with low affinity (Ka  =  1 nM) by itself, and 
that cotransfection of Bc with the chimeric IL-SRc~ leads to 
a fourfold increase (Kd  =  250 pM) in binding affinity (24). 
The usage of the chimeric IL-SRo~ may lead to somewhat 
different results from ours presented in this report. Recently, 
Tavernier et al. (25) reported that hlL-5 binding affinity of 
COS cells coexpressing the fuU-length hlL-5Rc~ and ~8r  is 
only twofold higher than that of COS cells expressing hlL- 
5Rc~ alone.  However,  it is  still not clear how the cross- 
competition of hlL-5 binding by hlL-3 or hGM-CSF occurs. 
It is supposed that binding of hlL-5 is irrelevant to the exis- 
tence of Be, as the binding affinity of ot alone does not differ 
so much from that of c~/B complex in contrast to hlL-3R 
and hGM-CSFR systems. The establishment of transfectant 
coexpressing  ~c and ot subunits  of hlL-5R,  hlL-3R,  and 
hGM-CSFR will answer this confusing question. 
In addition to receptors for IL-5, IL-3, and GM-CSF, sharing 
of signal-transducing  component has been demonstrated in 
receptors for IL-6, leukemia inhibitory factor (LIF), ciliary 
neurotropic factor (CNTF), and oncostatin M (26). In the 
IL-6R system, the cytoplasmic and transmembrane domains 
of the ligand binding subunit (p80 IL-6R) are not required 
to transduce the growth signal, since  the complex of the soluble 
form of pS0  IL-6R  and  IL-6  associates with  the signal- 
transducing subunit, gp130. There exist some differences be- 
tween the IL-5R and receptor systems that use gp130 as a 
signal transducer. First, not only extracellular but also trans- 
membrane regions of IL-5Rot are necessary to interact with 
B subunit. The anchoring of IL-5Rol is necessary for inter- 
acting with the/3 subunit, since the soluble form of mlL- 
5Ra inhibits binding of raiL-5 to IL-5-dependent cells (27) 
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and does not induce proliferation of FDC-P1 even  in the pres- 
ence oflL-5 (Kikuchi, Y., S. Takaki, and K. Takatsu, unpub- 
lished data). Second, the cytoplasmic domain of IL-5Rot plays 
an important role in transducing the IL-5 signal. Mutant IL- 
5Rot, which lacks the whole cytoplasmic domain, did not 
transduce the IL-5-mediated growth signal, though the in- 
teraction to AIC2B was not completely  impaired (Figs. 5 and 
6). It is not clear at this time, how the c~ subunit functions 
in signal transduction. Each c~ subunit of IL-5R, IL-3R, and 
GM-CSFR has conserved region (RLFPPX/vPxxxK/RxxL/ 
ixD) just underneath the transmembrane domain (4,  18). 
This region may be important to interact with the cytoplasmic 
domain of the common/3 subunit or with a certain common 
signal-transducing  molecule. The elements of the COOH- 
terminal region of the respective ol subunit diversified rela- 
tively from one another. The specific function of respective 
cytokine may depend on the structure of the distal part of 
the cytoplasmic portion of the c~ subunits. Or, each c~ subunit 
may simply support the function of the common/3 subunit 
by inducing conformational change or dimerization of the 
subunit. CTLL-2 cells transfected  with the chimeric receptor 
that consists of the extracellular domain of erythropoietin 
receptor (EPO-R) and the cytoplasmic domain of AIC2A, 
become responsive to EPO (28). Recent studies showed that 
EPO-R may be activated by homodimerization (29). If that 
is the case, homodimerization of the cytoplasmic domain of 
AIC2A may be sufficient  to transmit the IL-3-mediated signal. 
From a high degree of  homology  between AIC2A and AIC2B 
(6), it is supposed that similar dimerization mechanism may 
be involved in IL-5-mediated signal transduction. However, 
this may only be the case in the signal transduction for cell 
growth. In other cases, such as signals for B cells to induce 
differentiation for Ig-secreting cells, the cytoplasmic domain 
of the ot subunit may have some important roles in transmit- 
ting IL-5-specific signal. It is possible that there are several 
signal-transducing machineries that connect with the mem- 
brane receptors  to  the intracellular  device, and that some 
machineries function only in a limited cell type. 
A recent study (30) showed that the cytoplasmic region 
of ~/c has critical function in transducing growth signal. In 
addition, it was shown that the cytoplasmic region of hGM- 
CSFRot also has some roles in transmitting hGM-CSF-medi- 
ated signal (30). The transfectant ofmlL-3-dependent Ba/F3 
or  mlL-2-dependent  CTLL-2  expressing  mutant  hGM- 
CSFRoL and 3c does not respond  to hGM-CSF  at the be- 
ginning of culture, but adapts to response to hGM-CSF sev- 
eral days later (30). In the case of mlL-5Rol, the cytoplasmic 
domain was indispensable for transmitting signal, because 
the FCD-P1 transfectant expressing mutant IL-5RoL and the 
CTLL-2 transfectant  coexpressing  mutant IL-5Rol and AIC2B 
never became responsive to mlL-5. Even when the transfec- 
tants were cultured for several  weeks in the presence ofmlL-5, 
no IL-5-responsive transfectant grew up (data not shown). 
This discrepancy  between hGM-CSFR and mlL-5R may sug- 
gest the functional difference of each ~ subunit.  In addition, 
CTLL-2 transfectants expressing hlL-3Rot became respon- 
sive to hlL-3 because of the induction of the intrinsic AIC2B 
expression, whereas the transfectant expressing hGM-CSFRot expression, whereas the transfectant expressing hGM-CSFRoe 
did not induce any AIC2B expression  (31). There is an in- 
teresting report (32) showing that IL-3 and GM-CSF induce 
self-renewal  and  differentiation  activity,  respectively,  in 
different proportions in FDC-mix cells. These results may 
reflect the difference of signal-transmitting ability of each ee 
subunit. Further studies using mutant receptors and recon- 
stitution experiments in a variety of cell types will be re- 
quired to dissolve  the function of the common B subunit 
and ligand-specific  c~ subunits in signal transduction. 
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